Inadequate Medication Side Effects in Psychiatrical Pathology

被引:0
|
作者
Furnica, Cristina [1 ]
Constantin, Maria-Magdalena Leon [1 ]
Chistol, Raluca Ozana [1 ,2 ]
Alexa, Anisia-Iuliana [1 ]
Constantin, Stefan [3 ]
Tinica, Grigore [1 ,2 ]
机构
[1] Grigore T Popa Univ Med & Pharm Iasi, Fac Med, Iasi 700115, Romania
[2] Inst Cardiovasc Dis Iasi, Iasi 700503, Romania
[3] Gheorghe Asachi Tech Univ Iasi, Elect Engn & Appl Informat Fac, Iasi 700050, Romania
来源
REVISTA DE CHIMIE | 2015年 / 66卷 / 11期
关键词
dopamine antagonist; dopamine partial agonist; aripiprazole; olanzapine; biochemical interactions; atypical antipsychotics; SCHIZOPHRENIA; NOREPINEPHRINE; OLANZAPINE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Atypical antipsychotic drugs are the first-line of therapy in adult schizophrenia but their effects in children and adolescents have not been well understood. In the current paper there is presented a case of early-onset schizophrenia (EOS) with complex prodromal symptoms for 6 months prior to the acute psychotic episode, followed by an aggravation of the condition with a suicidal attempt secondary to inadequate medication with a dopamine antagonist and a dopamine partial agonist. The patient finally responded to aripiprazole monotherapy with lack of psychiatric symptoms and improvement of social integration for over a year. In our opinion, a multidisciplinary approach involving the research of biochemical interactions between antipsychotic drugs may allow a better understanding of mental diseases, which in turn will contribute to the establishment of the most appropriate diagnostic and therapeutic scheme.
引用
收藏
页码:1864 / 1866
页数:3
相关论文
共 50 条
  • [41] The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine
    Allan, ER
    Sison, CE
    Alpert, M
    Connolly, B
    Crichton, J
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (01) : 71 - 74
  • [42] Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats
    Boyda, H. N.
    Procyshyn, R. M.
    Tse, L.
    Wong, D.
    Pang, C. C.
    Honer, W. G.
    Barr, A. M.
    NEUROPHARMACOLOGY, 2012, 62 (03) : 1391 - 1400
  • [43] Cardiovascular Side Effects of Psychotropic Agents
    Qayyum, Zheala
    Zablan, Kashmir
    Zeshan, Muhammad
    Kalaskar, Saili
    Malik, Salma
    PSYCHIATRIC ANNALS, 2021, 51 (09) : 416 - 420
  • [44] Cognitive and affective side effects with aripiprazole
    Fischer-Barnicol, David
    Grohmann, Renate
    Stoppe, Gabriela
    PSYCHOPHARMAKOTHERAPIE, 2011, 18 (02): : 89 - +
  • [45] Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain
    Han, Mei
    Newell, Kelly
    Zavitsanou, Katerina
    Deng, Chao
    Huang, Xu-Feng
    JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (02) : 457 - 464
  • [46] Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
    Siafis, Spyridon
    Wu, Hui
    Wang, Dongfang
    Burschinski, Angelika
    Nomura, Nobuyuki
    Takeuchi, Hiroyoshi
    Schneider-Thoma, Johannes
    Davis, John M.
    Leucht, Stefan
    MOLECULAR PSYCHIATRY, 2023, 28 (08) : 3267 - 3277
  • [47] Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: Randomized double-blind placebo-controlled study
    Modabbernia, Amirhossein
    Heidari, Parvaneh
    Soleimani, Robabeh
    Sobhani, Abdolrasoul
    Roshan, Zahra Atrkar
    Taslimi, Shervin
    Ashrafi, Mandana
    Modabbernia, Mohammad Jafar
    JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 53 : 133 - 140
  • [48] Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics
    Caligiuri, Michael P.
    Teulings, Hans-Leo
    Dean, Charles E.
    Niculescu, Alexander B., III
    Lohr, James B.
    PSYCHIATRY RESEARCH, 2010, 177 (1-2) : 77 - 83
  • [49] Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
    Giulio Scigliano
    Gabriele Ronchetti
    CNS Drugs, 2013, 27 : 249 - 257
  • [50] Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine
    Danielle M. Santarelli
    Bing Liu
    Carlotta E. Duncan
    Natalie J. Beveridge
    Paul A. Tooney
    Peter R. Schofield
    Murray J. Cairns
    Psychopharmacology, 2013, 227 : 67 - 78